Ligand Pharma (LGND) Tops Q2 EPS by 141c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $286.29 -0.38%
Financial Fact:
Income (loss) before income taxes: 1.21M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Income (loss) before income taxes: 1.21M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q2 EPS of $1.81, $1.41 better than the analyst estimate of $0.40. Revenue for the quarter came in at $18.42 million versus the consensus estimate of $17 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
